Join our founder and CEO, Dr Zou Bin, together with nine other international biotech entrepreneurs to address unmet needs in oncology, and how these innovative startups work on new and exciting ideas for the benefit of cancer patients around the world. Find out more and register for the event here.


About Axcynsis Therapeutics Pte. Ltd.
Axcynsis Therapeutics Pte. Ltd. is a platform-based biotechnology company focusing on the development of Antibody Drug Conjugates (ADCs) to revolutionise cancer treatments. The Singapore biotech start-up leverages on proprietary technologies in its development of a robust pipeline of ADC candidates to address unmet medical needs for cancer treatment.

For all media queries, please contact: